Then, a follow-up analysis was conducted to determine whether complement levels and sENG fluctuate with gestational age and whether plasma adipsin and related important circulating complement molecules can be used as an early-pregnancy predictor and potential diagnostic biomarkers of preeclampsia. The gene discussed is CFD; the disease is preeclampsia.